Despite the strong growth forecast, the company's P/S is muc...
Despite the strong growth forecast, the company's P/S is much lower than expected causing investors to question its ability to achieve the future growth expectations. Market participants seem to be pricing in certain risks leading to this lowered P/S ratio.
Investors Continue Waiting On Sidelines For Fujian Aonong Biological Technology Group Incorporation Limited (SHSE:603363)
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment